ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,787Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 12

$595K Total Retail Price of All Prescriptions

Rank: 6 out of 12

288 Patients Receiving at Least One Drug in Part D
55%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 288 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

38% of this provider’s 288 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

3% of this provider’s 6,325 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 29.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 846 237 S3 1 5
FUROSEMIDE 337 250 2 2
OMEPRAZOLE 322 189 3 6
SIMVASTATIN 249 186 4 3
GABAPENTIN 236 68 5 14
LISINOPRIL 234 176 6 1
WARFARIN SODIUM 199 179 7 8
AMLODIPINE BESYLATE 173 111 8 7
POTASSIUM CHLORIDE 166 138 9 13
ZOLPIDEM TARTRATE 166 60 9 29
CYCLOBENZAPRINE HCL 157 72 R 11 93
ATENOLOL 145 108 12 22
METFORMIN HCL 141 67 13 12
FLUOXETINE HCL 140 75 14 62
PROAIR HFA 131 32 15 64
NEXIUM 131 70 15 45
ATORVASTATIN CALCIUM 128 70 17 18
LEVOTHYROXINE SODIUM 126 83 18 4
PANTOPRAZOLE SODIUM 125 84 19 31
METOPROLOL TARTRATE 121 88 20 10
DIGOXIN 113 79 21 42
PREDNISONE 110 64 22 51
PROMETHAZINE HCL 103 33 R 23 67
TAMSULOSIN HCL 97 50 24 27
CARBIDOPA-LEVODOPA 96 96 25 49
SPIRONOLACTONE 93 57 26 57
SULFAMETHOXAZOLE-TRIMETHOPRIM 90 47 27 39
LACTULOSE 89 89 28 68
TRAMADOL HCL 87 56 29 20
CITALOPRAM HBR 87 31 29 15
ENALAPRIL MALEATE 87 68 29 73
HYDROCHLOROTHIAZIDE 85 61 32 16
TRICOR 85 43 32 121
POLYETHYLENE GLYCOL 3350 84 70 34 19
CARVEDILOL 82 57 35 26
CYMBALTA 82 51 35 33
NAMENDA 81 81 37 11
CIPROFLOXACIN HCL 80 61 38 86
MELOXICAM 79 45 39 59
DONEPEZIL HCL 79 79 39 9
ROPINIROLE HCL 77 29 41 78
FENTANYL 76 76 S2 42 32
OXYCODONE HCL-ACETAMINOPHEN 75 22 S2 43 133
AMITRIPTYLINE HCL 68 25 R 44 140
FLUTICASONE PROPIONATE 68 44 44 41
ALLOPURINOL 67 46 46 52
PAROXETINE HCL 66 59 47 55
TRIAMTERENE-HCTZ 66 30 47 74
KLOR-CON 8 60 43 49 153
CLOPIDOGREL 58 33 50 33
CARISOPRODOL 56 0 R 51 158
VENLAFAXINE HCL ER 56 31 51 63
ADVAIR DISKUS 54 34 53 43
ISOSORBIDE MONONITRATE ER 52 52 54 60
PRAVASTATIN SODIUM 50 31 55 36
INSULIN SYRINGE 50 22 55 101
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.